Drug Patent Watch

MARCH 25, 2020

This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. [link] Drug developers require access to scientific information in…. The post Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average appeared first on DrugPatentWatch - Make Better Decisions.

Documentation 54

Documentation Drug Development 54

Med Ed 101

MARCH 25, 2020

Fluvoxamine drug interactions can be clinically significant in clinical practice. It is a major reason why this medication is not used very often. If you ever see it on a medication list of one of your patients, you must do a drug interaction screen. According to the package insert, fluvoxamine can inhibit CYP1A2, CYP2C9, CYP3A4, […]. The post Fluvoxamine Drug Interactions appeared first on Med Ed 101.

Packaging 40

Packaging 40

Med Ed 101

MARCH 22, 2020

The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is classified as an antimalarial agent, the most common, long term use for hydroxychloroquine that […].

40

40